By Newswire Editorial

Sri Lanka’s largest Western pharmaceutical manufacturing facility, currently under construction at the Bingiriya Investment Zone, aims to supply up to 25% of the country’s pharmaceutical requirements while also producing medicines for export markets.

According to the Ministry of Health, the facility, operated by Synergy Pharmaceuticals Corporation Private Limited, is currently in the final stages of construction.

Deputy Minister of Health Hansaka Wijemuni recently inspected the facility to assess the progress of construction, installation of modern machinery and development of its advanced Research and Development (R&D) Laboratory.

The factory is expected to manufacture a wide range of essential medicines, including tablets, capsules, injectable medicines, cancer treatment drugs and hormonal medications, in accordance with international quality standards.

The Ministry said the project is expected to strengthen Sri Lanka’s domestic pharmaceutical manufacturing capacity while creating opportunities to export locally manufactured medicines to international markets.

During the inspection, Deputy Minister Wijemuni assured that the government would continue to provide the necessary administrative assistance and institutional support to expedite the remaining construction work and commence commercial production.

A special discussion was also held regarding the factory’s future development plans.

Representatives of Synergy Pharmaceuticals’ management and other officials participated in the inspection. (Newswire)